Status:
UNKNOWN
Recurrent Extrahepatic Bile Duct Stones as a Late Complication of ERCP in Patients With Coexisting Intra- and Extrahepatic Bile Duct Stones
Lead Sponsor:
Air Force Military Medical University, China
Conditions:
Intrahepatic Bile Duct Stone
Choledocholithiasis
Eligibility:
All Genders
Brief Summary
The management of coexisting intrahepatic bile duct (IBD) and extrahepatic bile duct (EBD) stones is complicated and requires a multidisciplinary approach. The long-term clinical outcomes of patients ...
Eligibility Criteria
Inclusion
- non-gastrointestinal tract reconstruction patients with coexisting IBD and EBD stones who underwent ERCP between July 2008 and December 2020 at Xijing Hospital in China
Exclusion
- patients with benign or malignant EBD strictures
- sclerosing cholangitis
- suspected choledochal cysts
- liver cirrhosis
- parasitic liver diseases
- long-term biliary drainage with biliary stents or percutaneous tubes
- without a definitive IBD stone or with a diagnosis of liver calcification as determined by imaging review
- medical records or follow-up information was unavailable
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT06041113
Start Date
September 1 2023
End Date
July 1 2024
Last Update
September 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xijing Hospital of Digestive Diseases
Xi'an, Shaanxi, China, 710032